12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      High salt diet accelerates the progression of murine lupus through dendritic cells via the p38 MAPK and STAT1 signaling pathways

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The increased incidence of systemic lupus erythematosus (SLE) in recent decades might be related to changes in modern dietary habits. Since sodium chloride (NaCl) promotes pathogenic T cell responses, we hypothesize that excessive salt intake contributes to the increased incidence of autoimmune diseases, including SLE. Given the importance of dendritic cells (DCs) in the pathogenesis of SLE, we explored the influence of an excessive sodium chloride diet on DCs in a murine SLE model. We used an induced lupus model in which bone marrow-derived dendritic cells (BMDCs) were incubated with activated lymphocyte-derived DNA (ALD-DNA) and transferred into C57BL/6 recipient mice. We observed that a high-salt diet (HSD) markedly exacerbated lupus progression, which was accompanied by increased DC activation. NaCl treatment also stimulated the maturation, activation and antigen-presenting ability of DCs in vitro. Pretreatment of BMDCs with NaCl also exacerbated BMDC-ALD-DNA-induced lupus. These mice had increased production of autoantibodies and proinflammatory cytokines, more pronounced splenomegaly and lymphadenopathy, and enhanced pathological renal lesions. The p38 MAPK–STAT1 pathway played an important role in NaCl-induced DC immune activities. Taken together, our results demonstrate that HSD intake promotes immune activation of DCs through the p38 MAPK–STAT1 signaling pathway and exacerbates the features of SLE. Thus, changes in diet may provide a novel strategy for the prevention or amelioration of lupus or other autoimmune diseases.

          Related collections

          Most cited references83

          • Record: found
          • Abstract: found
          • Article: not found

          Systemic lupus erythematosus.

          Systemic lupus erythematosus is an autoimmune connective-tissue disorder with a wide range of clinical features, which predominantly affects women, especially from certain ethnic groups. Diagnosis is based on clinical assessment supported by investigations, including the finding of autoantibodies. Treatments range from antimalarial agents to corticosteroids and immunosuppressive agents. This Seminar draws attention to advances in the epidemiology, genetics, cardiovascular risks, lupus nephritis, CNS disease, the antiphospholipid syndrome, assessment of disease activity and damage, and pregnancy related and quality of life issues. New therapeutic approaches, such as biological agents and mycophenolate mofetil, will also be discussed.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients.

            Recent research in systemic lupus erythematosus (SLE) yielded new antigens and antibodies in SLE patients. We describe the various autoantibodies that can be detected in patients with SLE. A literature review, using the terms “autoantibody” and “systemic lupus erythematosus”, was conducted to search for articles on autoantibodies in SLE, their target antigens, association with disease activity and other clinical manifestations. One hundred and eighty autoantibodies were so far described in SLE patients. These include autoantibodies that target nuclear antigens, cytoplasmic antigens, cell membrane antigens, phospholipid-associated antigens, blood cells, endothelial cells, and nervous system antigens, plasma proteins, matrix proteins, and miscellaneous antigens. The target of an autoantibody, the autoantigen properties, autoantibody frequencies in SLE, as well as clinical associations, and correlation with disease activity are described for all 180 autoantibodies. SLE is so far the autoimmune disease with the largest number of detectable autoantibodies. Their production could be antigen-driven, the result of a polyclonal B cell activation, impaired apoptotic pathways, or the outcome of an idiotypic network dysregulation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              T cells in Systemic Lupus Erythematosus.

              Systemic Lupus Erythematosus is an autoimmune disorder caused by a complex combination of genetic, epigenetic and environmental factors. Different polymorphisms and epigenetic modifications lead to altered gene expression and function of several molecules which lead to abnormal T cell responses. Metabolic and functional alterations result in peripheral tolerance failures and biased differentiation of T cells into pro-inflammatory and B cell-helper phenotypes as well as the accumulation of disease-promoting memory T cells. Understanding these T cell alterations and their origins is necessary to develop more accurate patient classification systems and to discover new therapeutic targets.
                Bookmark

                Author and article information

                Contributors
                SongGuo.Zheng@osumc.edu
                Journal
                Signal Transduct Target Ther
                Signal Transduct Target Ther
                Signal Transduction and Targeted Therapy
                Nature Publishing Group UK (London )
                2095-9907
                2059-3635
                10 April 2020
                10 April 2020
                2020
                : 5
                : 34
                Affiliations
                [1 ]ISNI 0000 0004 1762 1794, GRID grid.412558.f, Department of Clinical Immunology, , The Third Affiliated Hospital at Sun Yat-sen University, ; 510630 Guangzhou, China
                [2 ]ISNI 0000 0001 2285 7943, GRID grid.261331.4, Department of Internal Medicine, , Ohio State University College of Medicine and Wexner Medical Center, ; Columbus, OH 43210 USA
                [3 ]ISNI 0000 0004 0543 9901, GRID grid.240473.6, Department of Medicine, , Penn State College of Medicine, ; Hershey, PA 17033 USA
                [4 ]ISNI 0000 0001 0807 1581, GRID grid.13291.38, Laboratory of Human Diseases and Immunotherapy, West China Hospital, , Sichuan University, ; Chengdu, China
                [5 ]ISNI 0000 0004 1797 9737, GRID grid.412596.d, Department of Internal Medicine, , The First Hospital of Harbin Medical University, ; Harbin, China
                [6 ]GRID grid.470124.4, Department of Allergy and Clinical Immunology, , The First Affiliated Hospital of Guangzhou Medical University, ; Guangzhou, China
                [7 ]ISNI 0000 0001 2186 0438, GRID grid.411667.3, Department of Pediatrics and Microbiology-Immunology, , Georgetown University Medical Center, ; Washington, DC USA
                Article
                139
                10.1038/s41392-020-0139-5
                7145808
                32296043
                1eef08c0-143b-421f-817c-cbc15392d983
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 24 September 2019
                : 8 January 2020
                : 20 January 2020
                Funding
                Funded by: FundRef https://doi.org/10.13039/100000009, Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.);
                Award ID: R01 AR059103
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100001809, National Natural Science Foundation of China (National Science Foundation of China);
                Award ID: 81871224
                Award ID: 81671611
                Award ID: 81901657
                Award ID: 81871224
                Award ID: 81671611
                Award ID: 81871224
                Award ID: 81871224
                Award ID: 81671611
                Award ID: 81871224
                Award ID: 81671611
                Award ID: 81671611
                Award ID: 81871224
                Award ID: 81671611
                Award ID: 81871224
                Award ID: 81671611
                Award ID: 81871224
                Award ID: 81671611
                Award ID: 81871224
                Award ID: 81671611
                Award Recipient :
                Funded by: National Key R&D Program of China [2017YFA0105801]; The Zhujiang Innovative and Entrepreneurial Talent Team Award of Guangdong Province [2016ZT06S252]; The Natural Science Foundation of Guangdong Province [Grant No. 2014A030308005]
                Funded by: National Key R&D Program of China [2017YFA0105801]; The Zhujiang Innovative and Entrepreneurial Talent Team Award of Guangdong Province [2016ZT06S252]; The Natural Science Foundation of Guangdong Province [Grant No. 2014A030308005]
                Funded by: FundRef https://doi.org/10.13039/501100011081, École Nationale d'Ingénieurs de Saint-Etienne (National Engineering School of Saint-Étienne);
                Award ID: 81671611
                Award Recipient :
                Funded by: National Key R&D Program of China [2017YFA0105801]; The Zhujiang Innovative and Entrepreneurial Talent Team Award of Guangdong Province [2016ZT06S252]; The Natural Science Foundation of Guangdong Province [Grant No. 2014A030308005]
                Funded by: National Key R&D Program of China [2017YFA0105801]; The Zhujiang Innovative and Entrepreneurial Talent Team Award of Guangdong Province [2016ZT06S252]; The Natural Science Foundation of Guangdong Province [Grant No. 2014A030308005]
                Funded by: National Key R&D Program of China [2017YFA0105801]; The Zhujiang Innovative and Entrepreneurial Talent Team Award of Guangdong Province [2016ZT06S252]; The Natural Science Foundation of Guangdong Province [Grant No. 2014A030308005]
                Funded by: National Key R&D Program of China [2017YFA0105801]; The Zhujiang Innovative and Entrepreneurial Talent Team Award of Guangdong Province [2016ZT06S252]; The Natural Science Foundation of Guangdong Province [Grant No. 2014A030308005]
                Funded by: National Key R&D Program of China [2017YFA0105801]; The Zhujiang Innovative and Entrepreneurial Talent Team Award of Guangdong Province [2016ZT06S252]; The Natural Science Foundation of Guangdong Province [Grant No. 2014A030308005]
                Funded by: National Key R&D Program of China [2017YFA0105801]; The Zhujiang Innovative and Entrepreneurial Talent Team Award of Guangdong Province [2016ZT06S252]; The Natural Science Foundation of Guangdong Province [Grant No. 2014A030308005]
                Funded by: National Key R&D Program of China [2017YFA0105801]; The Zhujiang Innovative and Entrepreneurial Talent Team Award of Guangdong Province [2016ZT06S252]; The Natural Science Foundation of Guangdong Province [Grant No. 2014A030308005]
                Funded by: National Key R&D Program of China [2017YFA0105801]; The Zhujiang Innovative and Entrepreneurial Talent Team Award of Guangdong Province [2016ZT06S252]; The Natural Science Foundation of Guangdong Province [Grant No. 2014A030308005]
                Categories
                Article
                Custom metadata
                © The Author(s) 2020

                rheumatology,immunology
                rheumatology, immunology

                Comments

                Comment on this article